Chiome Bioscience

Chiome Bioscience is a distinguished biotechnology company, established in 2005, specializing in pioneering research and development within antibody drug discovery and technology. Located in Shibuya, Tokyo, Chiome Bioscience is dedicated to shining a light on unmet medical needs and delivering a brighter future for patients through innovative solutions.

With a focus on the drug discovery business, Chiome Bioscience is actively engaged in the research and development of antibody drug pipelines. The company’s objective is to license these advancements to leading pharmaceutical companies, thereby broadening the reach and impact of their groundbreaking work. Chiome Bioscience also operates a robust drug discovery support business, forging partnerships and providing contract services to pharmaceuticals, diagnostics firms, biotechnology companies, and academic institutions.

Chiome Bioscience leverages its proprietary antibody generation (ADLib® system) and optimization technologies, along with advanced protein expression technologies, to deliver exceptional results. You can find Chiome Bioscience located at 3-12-1, Honmachi, Shibuya-Ku, Japan. The future is bright at Chiome Bioscience, where continuous innovation drives progress in biotechnology. We encourage the management team at Chiome Bioscience to enhance their presence further by creating a customized and exclusive company showcase and product listing on our platform.